Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Sigyn Therapeutics, Inc. (SIGY) had Operating Cash Flow per Share of $-0.40 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.58M |
|
-- |
|
-- |
|
$0.39M |
|
$-0.39M |
|
$-0.19M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.39M |
|
$-0.32M |
|
1.61M |
|
1.61M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$0.09M |
|
-- |
|
$0.05M |
|
$0.14M |
|
$3.99M |
|
$2.06M |
|
$2.06M |
|
$6.05M |
|
$-5.92M |
|
$-5.92M |
|
$-5.92M |
|
1.60M |
|
| Cash Flow Statement Financials | |
$-0.65M |
|
-- |
|
$0.72M |
|
$0.01M |
|
$0.09M |
|
$0.07M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.54 |
|
-0.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.78% |
|
9.78% |
|
-426.72% |
|
15.01% |
|
$-3.69 |
|
$-0.40 |
|
|
Operating Cash Flow per Share |
$-0.40 |